Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing.
暂无分享,去创建一个
J. Bell | A. Winstock | R. Mattick | B. Larance | L. Degenhardt | R. Ali | N. Lintzeris | P. Dietze | D. Horyniak